CONTRACEPTIVE CLINICAL TRIALS NETWORK (FEMALE)

避孕临床试验网络（女性）

• 批准号: 8337136
• 负责人: BRADFORD SEAMON
• 金额: $ 4.24万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2004
• 资助国家: 美国
• 起止时间: 2004-04-01 至 2011-04-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8337136
• 关键词: Advisory Committees; Clinical; Clinical Trials; Clinical Trials Network; Conduct Clinical Trials; Consultations; Contraceptive Agents; Contraceptive methods; Contractor; Contracts; Development; Devices; Female; Female Contraceptive Agents; Goals; Gynecologic; Human Resources; Levonorgestrel; Male Contraceptive Agents; National Institute of Child Health and Human Development; Notification; Pharmaceutical Preparations; Phase; Principal Investigator; Protocols documentation; Research; Research Design; Safety; Site; Specific qualifier value; base; drug candidate; programs; protocol development; treatment trial

The NICHD's Contraceptive Clinical Trials network conducts Phase I, II and III clinical trials of a wide variety of new female and male contraceptive methods. The objective of this contract is for CCTN contractors to conduct female contraceptive clinical trials, conduct treatment trials of gynecologic conditions, and to develop research protocols on a task Order basis under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Specifically, the levonorgestrel patch.

NICHD的避孕临床试验网络对各种新的女性和男性避孕方法进行第一、第二和第三阶段的临床试验。该合同的目的是让CCTN承包商进行女性避孕临床试验，进行妇科疾病的治疗试验，并根据不确定交付/不确定数量（IDIQ）合同，以任务订单为基础制定研究方案。尤其是左炔诺孕酮贴片。